SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir shares experienced extreme volatility as a sharp intraday selloff reversed following an unexpected social media post from President Trump, who praised the company's defense and war-fighting capabilities. This event sparked intense debate among the community, with many traders framing the price action as a clash between presidential market influence and the ongoing bearish arguments posed by figures like Michael Burry.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is facing a sharp sell-off driven by investor anxiety that AI-native competitors and agents could disrupt traditional SaaS workflows, leading to institutional downgrades and widespread sentiment shifts. Despite the heavy selling pressure and community debate over whether these concerns are overblown, market participants are split between those aggressively buying what they view as a generational discount and those bracing for further downside.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is seeing heavy volatility as the stock reacts to a massive $21 billion contract expansion with Meta, which is being partially offset by a $3 billion convertible note offering to fund rapid infrastructure growth. Community sentiment is deeply divided between investors viewing the capital raise as a necessary move to fuel a dominant AI backlog and traders expressing frustration over potential dilution causing price instability.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is surging as investors pivot to the company's critical role in wafer-level testing for silicon photonics and AI data center infrastructure, fueling a significant squeeze despite mixed quarterly earnings. The community is sharply divided, with bulls pointing to the company's record bookings and strategic positioning in the AI supply chain, while bears are aggressively shorting the stock, citing unsustainable market valuations, concerns over dilution, and weak historical revenue growth.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony is trending as investors react to the company's progress in restarting mining operations at Stibnite Hill and ongoing advancements in its proprietary hydrometallurgical processing technology. Community discussion remains polarized, with bulls highlighting the strategic importance of domestic critical mineral production and government contracts, while bears express skepticism regarding management's execution and historical financial performance.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Snowflake is facing significant downward pressure as investors rotate out of the software sector due to AI-driven disruption concerns and intense volatility ahead of the company's upcoming earnings release. While some in the community argue the stock is fundamentally oversold and essential for enterprise AI infrastructure, bearish sentiment remains elevated as traders monitor critical support levels and executive leadership changes.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. (ALOY) is attracting significant community attention due to its strategic positioning in the rare earth metals supply chain, buoyed by major contract awards and a new board featuring high-profile defense experts. While bullish investors emphasize its role in reducing dependency on foreign suppliers ahead of upcoming defense procurement mandates, some market participants remain cautious regarding the stock's recent volatility and the potential for long-term dilution as the company expands its production capabilities.

iShares Trust - iShares Expanded Tech-Software Sector ETF

iShares Expanded Tech-Software Sector ETF

Investors are closely monitoring the iShares Expanded Tech-Software Sector ETF as broader software indices show signs of a recovery. Market participants are actively debating the potential for sustained momentum in key enterprise software holdings as the sector attempts to rebound from recent volatility.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing significant investor scrutiny as it navigates a massive restructuring involving thousands of layoffs while concurrently committing to a multi-billion dollar expansion of its AI data center infrastructure. The market remains divided, with the community actively debating whether these aggressive cost-cutting measures are a necessary pivot to ensure future cloud relevance or a signal of deeper institutional concern over the company's debt levels and operational stability.

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.

Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals is capturing significant investor attention as shares trade substantially below the company's cash-on-hand value, fueling active community speculation regarding a potential buyout or strategic pivot. Sentiment is currently centered on the upcoming pivotal trial data readout and the impact of recent insider accumulation, with traders closely monitoring institutional activity and the company's clinical development roadmap.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Coeptis Therapeutics (NASDAQ:COEP) Trading Down 2.1%  - Here's What Happened

Coeptis Therapeutics (NASDAQ:COEP) Stock Price Down 2.1% - Here's What Happened...

Coeptis Therapeutics (NASDAQ:COEP) Stock Price Down 2.4% - Should You Sell?

Coeptis Therapeutics (NASDAQ:COEP) Shares Down 2.4% - Here's What Happened...

Coeptis Therapeutics (NASDAQ:COEP) Stock Price Down 19.7% - Should You Sell?

Coeptis Therapeutics (NASDAQ:COEP) Stock Price Down 19.7% - What's Next...

Coeptis Therapeutics (NASDAQ:COEP) Shares Down 19.7% - Should You Sell?

Coeptis Therapeutics (NASDAQ:COEP) Shares Down 19.7% - What's Next...

CSG Systems International Extraordinary General Meeting: Shareholders Back Key Proposals, Merger Actions

Coeptis Therapeutics Holdings Incorporated held its Annual and Special Meeting of Stockholders virtually, with Chief Executive Officer and Chairman Michael Mehalick presiding. The company noted the...

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) Short Interest Update

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP - Get Free Report) was the recipient of a significant increase in short interest in December. As of December 31st, there was short interest totaling...

Coeptis Therapeutics (NASDAQ:COEP) Trading Up 2.7% - Still a Buy?

Coeptis Therapeutics (NASDAQ:COEP) Trading Up 2.7% - Time to Buy...

Coeptis Therapeutics (NASDAQ:COEP) Stock Price Down 3.6% - Time to Sell?

Coeptis Therapeutics (NASDAQ:COEP) Shares Down 3.6% - What's Next...

Coeptis Therapeutics (NASDAQ:COEP) Stock Price Up 12.2% - What's Next?

Coeptis Therapeutics (NASDAQ:COEP) Stock Price Up 12.2% - Time to Buy...

This account has been verified as an official COEP representative.

Verified Account

Coeptis Therapeutics

Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. It operates through the Biotechnology and Technology segments. The Biotechnology segment is involved in developing biotechnology product pipelines. The Technology segment relates to acquiring technology assets to support and enhance operational capabilities through advanced technologies. The company was founded in 2017 and is headquartered in Wexford, PA.

Current Price	$12.21
Prev Close	$12.62
Open	$12.51
Dividend Yield	0.00%
50-Day Moving Average	$11.95
Beta	0.62
Avg. Volume	47,546.10
PE Ratio	-4.51

52-Week High	$21.41
52-Week Low	$6.26
Market Capitalization	$78.54M
EPS (Annual)	-$2.81
Price to Book	4.20
Revenue Per Employee	$227,174.17

COEP
Coeptis Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Latest COEP News

COEPCoeptis Therapeutics Inc